Prognostic parameters for flare in systemic lupus erythematosus

Revmatologiia

Volumn 39, Issue 12, 2000, Pages 1316-1319

  Mirzayan, M J ^a   Schmidt, R E ^a   Witte, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Flares; Prognosis; SLE; SLEDAI

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA;

ADULT; AGED; ANEMIA; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANEMIA; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOPENIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 0034515433     PISSN: 13100505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Hochberg MC. Systemic lupus erythematosus. Rheum Dis Clin North Am 1990;16:617-39.
2. Hughes GRV, Cohen SA, Christian CL. Anti-DNA activity in systemic lupus erythematosus: a diagnostic and therapeutic guide. Ann Rheum Dis 1971;30:259-64.
3. Lloyd W, Schur PH. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine 1981;60:208-17.
4. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine 1989;68:141-50.
5. Jacobsen S, Petersen J, Ullman S, Junker P, Voss A, Rasmussen JM et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 1998;17:478-84.
6. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine 1999; 78:167-75.
7. Swaak AJG, Nossent JC, Bronsveld W, van Rooyen A, Nieuwenhuys EJ, Theuns L et al. Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989;48:447-60.
8. Symmons DPM, Coppock JS, Bacon PA, Bresnihan B, Isenberg DA, Maddison P et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Q J Med 1988;69:927-33.
9. Petri M, Genovese M, Engle E, Hochberg M. Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 1991;34:937-44.
10. Zonana-Nacach A, Salas M, Lourdes Sanchez MD, Camargo-Coronel A, Bravo-Gatica C, Mintz G. Measurement of clinical activity of systemic lupus erythematosus and laboratory abnormalities: A 12-month prospective study. J Rheumatol 1995;22:45-9.
11. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40: 1725.
14. Walz LeBlanc BA, Gladman DD, Urowitz MB. Serologically active clinically quiescent systemic lupus erythematosus - predictors of clinical flares. J Rheumatol 1994;21:2239-41.
15. Nossent JC. Course and prognostic value of systemic lupus erythematosus disease activity index in black Caribbean patients. Semin Arthritis Rheum 1993;23: 16-21.
16. Swaak AJ, Groenwold J, Bronsveld W. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986;45:359-66.